Cargando…

Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials

Context: Graves’ orbitopathy (GO) an autoimmune disease in orbit, characterized with proptosis due to excessive proliferation, adipogenesis, fibrosis and hyaluronan secretion of orbital fibroblasts (OFs). OFs is potential to be a target for proptosis. But there are few effective therapies. Objective...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yan, Li, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090498/
http://dx.doi.org/10.1210/jendso/bvab048.987
_version_ 1783687297972043776
author Guo, Yan
Li, Yanbing
author_facet Guo, Yan
Li, Yanbing
author_sort Guo, Yan
collection PubMed
description Context: Graves’ orbitopathy (GO) an autoimmune disease in orbit, characterized with proptosis due to excessive proliferation, adipogenesis, fibrosis and hyaluronan secretion of orbital fibroblasts (OFs). OFs is potential to be a target for proptosis. But there are few effective therapies. Objectives: Our present purpose was to evaluate the effects of artemisinin (ARS) and the derivatives dihydroartemisinin (DHA), artesunate (ART) on OFs from GO patients in vitro. Design/Setting/Participants: OFs isolated from patients with GO (n = 10) were allowed to proliferate in the proliferation medium (PM); differentiate into adipocytes in the differentiation medium (DM) or differentiate into myofibroblast stimulated by TGF-β (10ng/ml); or produce hyaluronan stimulated by IL-1β (5ng/ml). Different dosages of ARS and the derivatives were administered in the above conditions. Main Outcome Measures: CCK-8 was used to assessed cell viability of OFs, EdU incorporation and flow cytometry were conducted to assess cellular proliferation. Adipogenesis was determined by Western blot and Oil Red O staining. Hyaluronan was quantified by ELISA. Fibrosis was assessed using Western blot. Results: ARS in concentrations lower than 100 μM, DHA < 20 μM and ART < 10 μM are nontoxic for OFs. Cellular proliferation of GO-OFs was halted by ARS and its derivatives at the maximum nontoxic dosage. ARS and its derivatives exerted an inhibitory action on adipogenesis of OFs in a concentration-dependent manner. Moreover, hyaluronan secretion was obviously decreased by ARS and its derivatives. Intriguingly, fibrosis markers were also decreased by the antimalarias in a dosage-dependent way. Conclusions: We elucidated the efficacies of ARS and its derivatives on proliferation, adipogenesis, fibrosis and hyaluronan production of OFs, supporting that ARS-based antimalarials play potential role as a novel therapy for GO from a perspective of in-vitro study.
format Online
Article
Text
id pubmed-8090498
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80904982021-05-05 Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials Guo, Yan Li, Yanbing J Endocr Soc Endocrine Disruption Context: Graves’ orbitopathy (GO) an autoimmune disease in orbit, characterized with proptosis due to excessive proliferation, adipogenesis, fibrosis and hyaluronan secretion of orbital fibroblasts (OFs). OFs is potential to be a target for proptosis. But there are few effective therapies. Objectives: Our present purpose was to evaluate the effects of artemisinin (ARS) and the derivatives dihydroartemisinin (DHA), artesunate (ART) on OFs from GO patients in vitro. Design/Setting/Participants: OFs isolated from patients with GO (n = 10) were allowed to proliferate in the proliferation medium (PM); differentiate into adipocytes in the differentiation medium (DM) or differentiate into myofibroblast stimulated by TGF-β (10ng/ml); or produce hyaluronan stimulated by IL-1β (5ng/ml). Different dosages of ARS and the derivatives were administered in the above conditions. Main Outcome Measures: CCK-8 was used to assessed cell viability of OFs, EdU incorporation and flow cytometry were conducted to assess cellular proliferation. Adipogenesis was determined by Western blot and Oil Red O staining. Hyaluronan was quantified by ELISA. Fibrosis was assessed using Western blot. Results: ARS in concentrations lower than 100 μM, DHA < 20 μM and ART < 10 μM are nontoxic for OFs. Cellular proliferation of GO-OFs was halted by ARS and its derivatives at the maximum nontoxic dosage. ARS and its derivatives exerted an inhibitory action on adipogenesis of OFs in a concentration-dependent manner. Moreover, hyaluronan secretion was obviously decreased by ARS and its derivatives. Intriguingly, fibrosis markers were also decreased by the antimalarias in a dosage-dependent way. Conclusions: We elucidated the efficacies of ARS and its derivatives on proliferation, adipogenesis, fibrosis and hyaluronan production of OFs, supporting that ARS-based antimalarials play potential role as a novel therapy for GO from a perspective of in-vitro study. Oxford University Press 2021-05-03 /pmc/articles/PMC8090498/ http://dx.doi.org/10.1210/jendso/bvab048.987 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Endocrine Disruption
Guo, Yan
Li, Yanbing
Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title_full Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title_fullStr Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title_full_unstemmed Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title_short Artemisinin and the Derivatives Play Novel Role in Treatment for Graves’ Orbitopathy as Conventional Antimalarials
title_sort artemisinin and the derivatives play novel role in treatment for graves’ orbitopathy as conventional antimalarials
topic Endocrine Disruption
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090498/
http://dx.doi.org/10.1210/jendso/bvab048.987
work_keys_str_mv AT guoyan artemisininandthederivativesplaynovelroleintreatmentforgravesorbitopathyasconventionalantimalarials
AT liyanbing artemisininandthederivativesplaynovelroleintreatmentforgravesorbitopathyasconventionalantimalarials